Trial intelligence / Profile preview

Optimizing Premedication to Prevent Emergence Delirium in Children Undergoing Ambulatory Surgery: Oral Dexmedetomidine Versus Midazolam

TCTR20260330002Phase 2Completed

Sponsor
Chatchayapa Rathanasutthajohn, MD
Start
Apr 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of dexmedetomidine, midazolam in Emergence agitation (EA), sponsored by Chatchayapa Rathanasutthajohn, MD. Started Apr 2026; status: completed.

02

Drugs

dexmedetomidinemidazolam
03

Conditions

Emergence agitation (EA)

Beyond the preview

Go deeper on TCTR20260330002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20260330002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call